Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Veto of Prescription Drug…
Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…
Learn more
BIO Statement on Resignation of FDA Commissioner…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…
Learn more
BIO Launches “The Fight of Our Lives,” a National…
WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of ​​The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Statement on Supreme Court Ruling in Impression Products v. Lexmark International
May 30, 2017
Washington, DC (May 30, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to the Supreme Court’s ruling in Impression Products  v. Lexmark International.
POET Founder, Chairman and CEO Jeff Broin to Receive 2017 BIO George Washington Carver Award
May 25, 2017
BIO today announced that POET Founder, Chairman and CEO Jeff Broin will receive the 10th annual George Washington Carver Award for Innovation in Industrial Biotechnology. The award will be presented on Monday July 24, 2017, during a morning plenary…
BIO Applauds Creation of FDA Opioid Policy Steering Committee
May 24, 2017
Washington, DC (May 24, 2017) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement regarding the announced creation of an Opioid Policy Steering Committee at the Food and Drug…
Astellas Expands Advocacy Engagement with Focused Outreach
May 23, 2017
Astellas recognizes the crucial role that patient groups play in enhancing and extending the lives of patients. Sponsoring events such as the BIO Patient and Health Advocacy Summit to be held on November 3-4 is a way the Astellas…
BIO Statement on President’s Proposed 2018 Budget
May 23, 2017
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement in response to President Trump’s FY 2018 budget proposal.
Biotech Industry Continues Strong Growth in 2016; San Diego Setting Pace for State, Nation
May 17, 2017
Mayor Faulconer, Industry Leaders Reveal Latest Data, Including Major Economic Benefits of June BIO 2017 Convention
BIO Joins Diverse Coalition Promoting Market-Based Solutions to Address Prescription Drug Costs, Increase Patient Access and Choice
May 17, 2017
Washington, DC (May 17, 2017) – Today, the Biotechnology Innovation Organization (BIO) joins with a diverse coalition of stakeholders in endorsing a set of pro-competition, free-market-oriented solutions to lower healthcare costs while…
BIO Submits Comments to EPA Regulatory Reform Task Force
May 16, 2017
BIO submitted comments to the Environmental Protection Agency’s Regulatory Reform Task Force on Executive Order 13777 “Enforcing the Regulatory Reform Agenda.”
BIO Statement on the Passing of Biotechnology Giant Henri Termeer
May 15, 2017
Termeer was a key architect in the founding of BIO, a mentor to countless entrepreneurs, executives and researchers, and passionate in his pursuit of innovative patient-centric drug development. Washington, DC (May 15, 2017) – Henri…
BIO Statement on U.S.-China Comprehensive Economic Dialogue
May 12, 2017
Washington, D.C. (May 12, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding initial results of the 100-Day Action Plan of the U.S.-China Comprehensive Economic Dialogue: